GlassScriptPhysician profile
Jashoman Banerjee
NPI 1386804144
$617.22
in general payments reported to CMS, 2019-2025
9 companies · $69.45 in 2025
The $69.45 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.85 · 2021: $78.85 · 2022: $76.55 · 2023: $343 · 2024: $17.68 · 2025: $69.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $429.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $151.90 | 2023-2025 | Follistim Aq |
| Sumitomo Pharma America, INC. | $139.63 | 2023 | Myfembree |
| Abbvie INC. | $117.24 | 2021-2023 | Lo Loestrin Fe, Orilissa |
| Ferring Pharmaceuticals INC. | $110.00 | 2019-2024 | Menopur |
| Dexcom, INC. | $37.06 | 2025 | Dexcom G6 Transmitter |
| Galen US INC | $18.87 | 2021 | |
| Novo Nordisk INC | $15.55 | 2023 | Saxenda, Wegovy |
| Mallinckrodt Enterprises LLC | $13.93 | 2019 | |
| Pfizer INC. | $13.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jashoman Banerjee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.